{"id":"fentanyl-intranasal","safety":{"commonSideEffects":[{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1201159","moleculeType":"Small molecule","molecularWeight":"372.94"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fentanyl activates mu-opioid receptors throughout the brain and spinal cord, inhibiting pain signal transmission and producing rapid analgesia. The intranasal formulation allows for non-invasive, rapid absorption through nasal mucosa, providing faster onset than oral routes while avoiding first-pass hepatic metabolism. This route is particularly useful in pediatric populations for acute pain management and procedural sedation.","oneSentence":"Fentanyl is a potent synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:22.501Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute pain management in pediatric patients"},{"name":"Procedural sedation and analgesia in children"}]},"trialDetails":[{"nctId":"NCT06464146","phase":"PHASE3","title":"Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-26","conditions":"Limb Injury","enrollment":300},{"nctId":"NCT07299630","phase":"PHASE3","title":"Blocking Sphenopalatine Ganglion by Intranasal Lidocaine Spray in Partial Turbinectomy Surgeries","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-12-20","conditions":"Turbinate Surgery, Sphenopalatine Block","enrollment":50},{"nctId":"NCT07120763","phase":"PHASE3","title":"Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures","status":"RECRUITING","sponsor":"State University of New York at Buffalo","startDate":"2025-08-22","conditions":"Distal Radius Fracture Reduction, Pain Control, Pediatric Fractures","enrollment":50},{"nctId":"NCT07190625","phase":"EARLY_PHASE1","title":"Intranasal Versus Intravenous Fentanyl For Procedural Analgesia in Preterm Neonates","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2023-12-24","conditions":"Procedural Pain","enrollment":75},{"nctId":"NCT07166666","phase":"NA","title":"Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2025-09-01","conditions":"Sedation, Analgesia Assessment","enrollment":128},{"nctId":"NCT05057689","phase":"PHASE2","title":"Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room","status":"WITHDRAWN","sponsor":"Nationwide Children's Hospital","startDate":"2025-09","conditions":"Acute Stress Disorder, Anxiety, Pain","enrollment":""},{"nctId":"NCT07148882","phase":"PHASE2, PHASE3","title":"Pain Managment in Preterm Neonates","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-02-01","conditions":"Preterm Neonates Pain Managment, PreTerm Neonate","enrollment":52},{"nctId":"NCT02095366","phase":"PHASE4","title":"Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2013-08-02","conditions":"Severe Traumatic Pain, Numeric Pain Rating Scale > 5 / 10","enrollment":194},{"nctId":"NCT07112430","phase":"PHASE1, PHASE2","title":"Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"IWK Health Centre","startDate":"2025-10-01","conditions":"Neonatal Pain, Retinopathy of Prematurity (ROP), Pain Management","enrollment":50},{"nctId":"NCT06719986","phase":"PHASE1","title":"Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2022-10-03","conditions":"Opioid Overdose","enrollment":24},{"nctId":"NCT06633900","phase":"PHASE2, PHASE3","title":"Naltrexone for Overdose Prevention","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-04-10","conditions":"Overdose Accidental","enrollment":100},{"nctId":"NCT06281951","phase":"PHASE1","title":"Nebulized Fentanyl in Healthy Volunteers","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2024-04-26","conditions":"Analgesia, Emergencies","enrollment":20},{"nctId":"NCT06590870","phase":"PHASE3","title":"Intranasal Fentanyl in Preterm Infants Undergoing Peripherally Inserted Central Catheter Placement","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2024-08-09","conditions":"Procedural Pain","enrollment":8},{"nctId":"NCT06832046","phase":"","title":"Evaluation of the \"Intranasal Fentanyl\" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2024-10-28","conditions":"Musculoskeletal Pain","enrollment":500},{"nctId":"NCT05338632","phase":"PHASE1","title":"Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2022-06-24","conditions":"Opioid Induced Respiratory Depression, Chronic Opioid Use","enrollment":24},{"nctId":"NCT06051227","phase":"PHASE3","title":"Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-01-11","conditions":"Acute Pain Due to Trauma, Analgesia, Fentanyl","enrollment":608},{"nctId":"NCT06181695","phase":"PHASE3","title":"Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-05-02","conditions":"Vaso-occlusive Crisis","enrollment":182},{"nctId":"NCT05137184","phase":"PHASE3","title":"A Comparison of Three Regimens of Acute Pain Management: Methoxyflurane; Intranasal Fentanyl; Intravenous Morphine","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2021-11-12","conditions":"Acute Pain, Ambulances","enrollment":338},{"nctId":"NCT05508594","phase":"PHASE2, PHASE3","title":"Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001","status":"COMPLETED","sponsor":"Cessatech A/S","startDate":"2022-09-05","conditions":"Pain","enrollment":220},{"nctId":"NCT03872700","phase":"PHASE3","title":"Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2019-08-01","conditions":"Abscess","enrollment":49},{"nctId":"NCT03348423","phase":"PHASE2","title":"Evaluation of DEX-IN During Outpatient Procedures","status":"COMPLETED","sponsor":"Baudax Bio","startDate":"2017-11-15","conditions":"Pain","enrollment":45},{"nctId":"NCT05848505","phase":"NA","title":"Opioid-sparing Effect of Intranasal Dexmedetomidine","status":"COMPLETED","sponsor":"Pierre-Yves P Lequeux","startDate":"2022-02-25","conditions":"Tonsillar Hypertrophy","enrollment":50},{"nctId":"NCT02571179","phase":"PHASE4","title":"Intranasal Fentanyl in Treatment of Labour Pain","status":"COMPLETED","sponsor":"Kuopio University Hospital","startDate":"2011-01","conditions":"Labor Pain","enrollment":20},{"nctId":"NCT05604599","phase":"PHASE4","title":"Intranasal Versus Intravenous Dexmedetomidine for Hypotensive Anesthesia in FESS","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2022-11-10","conditions":"Functional Endoscopic Sinus Surgery, Premedication, Analgesia","enrollment":60},{"nctId":"NCT04076748","phase":"PHASE3","title":"Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2021-07-20","conditions":"Sickle Cell Crisis","enrollment":196},{"nctId":"NCT02866071","phase":"PHASE3","title":"Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jason McMullan","startDate":"2017-10-03","conditions":"Acute Traumatic Pain","enrollment":224},{"nctId":"NCT02985177","phase":"PHASE4","title":"A RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture","status":"WITHDRAWN","sponsor":"St. Justine's Hospital","startDate":"2020-01","conditions":"Emergency Service, Hospital, Child/Adolescent Problem, Acute Pain","enrollment":""},{"nctId":"NCT02521415","phase":"PHASE2","title":"IN Sub-Dissociative Ketamine vs IN Fentanyl","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2015-12","conditions":"Bone Fracture","enrollment":87},{"nctId":"NCT02653742","phase":"PHASE4","title":"Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children","status":"UNKNOWN","sponsor":"Anica Crnkovic","startDate":"2015-05","conditions":"Pain, Postoperative, Otitis Media","enrollment":150},{"nctId":"NCT03528512","phase":"PHASE4","title":"IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair","status":"TERMINATED","sponsor":"Corewell Health East","startDate":"2018-09-04","conditions":"Laceration of Skin","enrollment":5},{"nctId":"NCT04807335","phase":"PHASE1","title":"Study of CT001 in Healthy Volunteers","status":"COMPLETED","sponsor":"Cessatech A/S","startDate":"2021-03-17","conditions":"Bioavailability","enrollment":14},{"nctId":"NCT02459964","phase":"PHASE4","title":"Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-09-14","conditions":"Advanced Cancers, Pain","enrollment":84},{"nctId":"NCT04621110","phase":"PHASE3","title":"Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2021-06-01","conditions":"Pediatric Cancer, Analgesia, Procedural Pain","enrollment":60},{"nctId":"NCT04745260","phase":"NA","title":"Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair","status":"UNKNOWN","sponsor":"University of Texas at Austin","startDate":"2021-03-01","conditions":"Facial Laceration, Anxiety","enrollment":100},{"nctId":"NCT04137198","phase":"PHASE4","title":"Sufentanil Intranasal","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Saint Pierre","startDate":"2020-01-22","conditions":"Emergencies, Pain, Acute, Analgesia","enrollment":170},{"nctId":"NCT03063359","phase":"PHASE3","title":"Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma","status":"TERMINATED","sponsor":"University Hospital, Montpellier","startDate":"2017-05-30","conditions":"Pain, Acute","enrollment":22},{"nctId":"NCT01906073","phase":"PHASE3","title":"Nasal Fentanyl for Chronic Cancer Pain","status":"WITHDRAWN","sponsor":"Norwegian University of Science and Technology","startDate":"2017-01","conditions":"Cancer, Pain","enrollment":""},{"nctId":"NCT02638506","phase":"PHASE4","title":"RCT Evaluating Intranasal Fentanyl in the Pain Management of Children With Headaches","status":"TERMINATED","sponsor":"St. Justine's Hospital","startDate":"2016-01","conditions":"Headaches","enrollment":62},{"nctId":"NCT02778880","phase":"PHASE3","title":"Pain Reduction With Intranasal Medications for Extremity Injuries","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2016-03-31","conditions":"Pain, Traumatic Limb Injury","enrollment":90},{"nctId":"NCT04414800","phase":"PHASE3","title":"Intranasal Ketamine Versus Intranasal Fentanyl","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2017-04-01","conditions":"Multiple Trauma, Pain, Acute","enrollment":125},{"nctId":"NCT03809455","phase":"PHASE2","title":"Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients","status":"WITHDRAWN","sponsor":"UNICANCER","startDate":"2020-02-01","conditions":"Breakthrough Pain","enrollment":""},{"nctId":"NCT03421275","phase":"PHASE4","title":"Intranasal Esketamine and Fentanyl for Pain in Minor Trauma","status":"UNKNOWN","sponsor":"Anna Meuronen, MD","startDate":"2017-12-01","conditions":"Acute Pain Due to Trauma","enrollment":105},{"nctId":"NCT03071744","phase":"PHASE2","title":"Lazanda in Cancer Patients Receiving Palliative Radiation","status":"TERMINATED","sponsor":"Joseph Ma","startDate":"2017-03-01","conditions":"Bone Metastases","enrollment":6},{"nctId":"NCT03912090","phase":"","title":"Intranasal Fentanyl for the Treatment of Acute Severe Pain on the Pediatric Emergency Department of Mercy Hospital.","status":"COMPLETED","sponsor":"Centre Hospitalier Régional Metz-Thionville","startDate":"2018-10-30","conditions":"Acute Pain","enrollment":83},{"nctId":"NCT01549002","phase":"PHASE3","title":"Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children","status":"COMPLETED","sponsor":"Columbia University","startDate":"2012-01","conditions":"Abscess, Pain","enrollment":20},{"nctId":"NCT03682211","phase":"PHASE4","title":"Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children","status":"COMPLETED","sponsor":"University College Dublin","startDate":"2012-12-12","conditions":"Pain, Sickle Cell Disease","enrollment":31},{"nctId":"NCT03057041","phase":"NA","title":"Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration","status":"COMPLETED","sponsor":"University of Hawaii","startDate":"2017-03-23","conditions":"Pain Uterus","enrollment":107},{"nctId":"NCT02298582","phase":"PHASE2, PHASE3","title":"Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2014-12-08","conditions":"Pain Due to Certain Specified Procedures","enrollment":58},{"nctId":"NCT02388321","phase":"PHASE4","title":"Pediatric Ketamine Study for Pain Management","status":"TERMINATED","sponsor":"Antonios Likourezos","startDate":"2015-05-01","conditions":"Pain","enrollment":22},{"nctId":"NCT02125201","phase":"PHASE4","title":"Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2014-06","conditions":"Pain","enrollment":21},{"nctId":"NCT02533908","phase":"PHASE3","title":"Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children","status":"COMPLETED","sponsor":"University Children's Hospital, Zurich","startDate":"2015-09-21","conditions":"Inhalation of Nitrous Oxide, Opioid Analgesic Adverse Reaction, Pain","enrollment":402},{"nctId":"NCT02454751","phase":"PHASE2","title":"The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial","status":"COMPLETED","sponsor":"St. Boniface Hospital","startDate":"2015-10","conditions":"Dyspnea, Congestive Heart Failure","enrollment":8},{"nctId":"NCT03224039","phase":"PHASE4","title":"Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain","status":"UNKNOWN","sponsor":"The Brooklyn Hospital Center","startDate":"2017-01-01","conditions":"Acute Pain","enrollment":40},{"nctId":"NCT01012999","phase":"PHASE1, PHASE2","title":"A Dosing and Efficacy Study of Intra-nasal Sufentanil for Moderate to Severe Pain","status":"TERMINATED","sponsor":"University of Utah","startDate":"2009-11","conditions":"Pain, Opiate","enrollment":16},{"nctId":"NCT01756651","phase":"PHASE1","title":"Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures","status":"COMPLETED","sponsor":"Richard C Reznichek, MD","startDate":"2013-02","conditions":"Other Acute Pain, Pain Experienced During Cystoscopy","enrollment":20},{"nctId":"NCT02635282","phase":"PHASE4","title":"IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D","status":"COMPLETED","sponsor":"University of Tennessee","startDate":"2016-08","conditions":"Abscess, Pain","enrollment":19},{"nctId":"NCT01954368","phase":"PHASE4","title":"Intranasal Sufentanil Pain-management at Entrance of Emergency Department : Influence on Pain-relief Delay","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2014-01","conditions":"Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale)","enrollment":144},{"nctId":"NCT02571634","phase":"PHASE4","title":"Lazanda Fentanyl Nasal Spray Pre Radiofrequency Nerve Ablations(RFA) of Lumbar Facet Joints","status":"COMPLETED","sponsor":"Defense and Veterans Center for Integrative Pain Management","startDate":"2015-05","conditions":"Minor Procedural Pain","enrollment":23},{"nctId":"NCT01482091","phase":"PHASE4","title":"Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2011-12","conditions":"Anemia, Sickle Cell, Pain","enrollment":124},{"nctId":"NCT01244126","phase":"PHASE4","title":"Postoperative Effects of Intranasal Fentanyl, IV and IM Morphine in Children Undergoing Myringotomy","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2008-05","conditions":"Otitis Media","enrollment":171},{"nctId":"NCT01708122","phase":"PHASE4","title":"Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2009-05","conditions":"Pain","enrollment":71},{"nctId":"NCT02050503","phase":"","title":"Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis","status":"COMPLETED","sponsor":"Grupo de Investigación Clínica en Oncología Radioterapia","startDate":"2012-12","conditions":"Breakthrough Pain, Mucositis, Radiotherapy","enrollment":33},{"nctId":"NCT02222636","phase":"PHASE4","title":"The Clinical Research of Intranasal Dexmedetomidine Used in Plastic Surgery of Children","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2014-09","conditions":"The Efficacy and Safety of Intranasal Dexmedetomidine","enrollment":60},{"nctId":"NCT01188551","phase":"PHASE2, PHASE3","title":"Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2011-01","conditions":"Chronic Otitis Media","enrollment":100},{"nctId":"NCT01429051","phase":"PHASE3","title":"A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain","status":"COMPLETED","sponsor":"Takeda","startDate":"2011-08","conditions":"Break Through Pain, Cancer","enrollment":46},{"nctId":"NCT01693328","phase":"","title":"Patient Satisfaction and Quality of Life Impact - PecFent®","status":"UNKNOWN","sponsor":"Archimedes Development Ltd","startDate":"2012-09","conditions":"Breakthrough Cancer Pain","enrollment":300},{"nctId":"NCT02022488","phase":"PHASE4","title":"Sevoflurane Induced Emergence Agitation","status":"COMPLETED","sponsor":"Yeditepe University Hospital","startDate":"2012-02","conditions":"Emergence Agitation","enrollment":78},{"nctId":"NCT01304342","phase":"NA","title":"Sedation in Endoscopic Retrograde Cholangiopancreatography (ERCP) With or Without Opioids","status":"COMPLETED","sponsor":"University of Athens","startDate":"2011-02","conditions":"Chronic Pain","enrollment":180},{"nctId":"NCT01698645","phase":"","title":"Patient Satisfaction and Quality of Life Impact - PecFent®","status":"UNKNOWN","sponsor":"Archimedes Development Ltd","startDate":"2012-09","conditions":"Breakthrough Cancer Pain","enrollment":150},{"nctId":"NCT01045603","phase":"","title":"Instanyl® Non-Interventional Study","status":"COMPLETED","sponsor":"Takeda","startDate":"2009-12","conditions":"Breakthrough Cancer Pain","enrollment":309},{"nctId":"NCT01497288","phase":"PHASE1","title":"A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects","status":"COMPLETED","sponsor":"Takeda","startDate":"2011-11","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT00994760","phase":"","title":"Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years","status":"COMPLETED","sponsor":"Takeda","startDate":"2009-09","conditions":"Breakthrough Pain, Cancer","enrollment":131},{"nctId":"NCT00362583","phase":"PHASE3","title":"Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2006-06","conditions":"Cancer","enrollment":100},{"nctId":"NCT00345735","phase":"PHASE2","title":"Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2006-05","conditions":"Cancer, Pain","enrollment":150},{"nctId":"NCT00882960","phase":"PHASE4","title":"Intranasal Fentanyl for Pain Management","status":"UNKNOWN","sponsor":"Genesys","startDate":"2009-04","conditions":"Trauma, Pain","enrollment":500},{"nctId":"NCT00654329","phase":"PHASE4","title":"Dexmedetomidine vs Fentanyl for BMT","status":"COMPLETED","sponsor":"Children's National Research Institute","startDate":"2005-08","conditions":"Otitis","enrollment":101},{"nctId":"NCT00405444","phase":"PHASE3","title":"Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2006-11","conditions":"Pain","enrollment":64}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Fentanyl Sintetica"],"phase":"phase_3","status":"active","brandName":"Fentanyl intranasal","genericName":"Fentanyl intranasal","companyName":"University Children's Hospital, Zurich","companyId":"university-children-s-hospital-zurich","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fentanyl is a potent synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation. Used for Acute pain management in pediatric patients, Procedural sedation and analgesia in children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}